Markets:

Overview

News

Currencies

International

Treasuries

Avantis International Equity ETF (NY:AVDE)

78.51 +0.28 (+0.36%)

Official Closing Price Updated: 4:10 PM EST, Nov 24, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Avantis International Equity ETF

< Previous 1 2 Next >

Novo Nordisk Reportedly Slashes Workforce At Its US Wegovy Manufacturing Plant ↗

October 07, 2025

Via Stocktwits

Novo Nordisk To Reportedly Cut Yearly Bonus For Denmark Employees: Retail Expects Stock To Hit $80 By Year-End ↗

August 22, 2025

Via Stocktwits

Budweiser Maker’s Stock Gets Crushed After Q2 Gloom — Retail Traders Feel 'Drop Is A Bit Unjustified' ↗

August 01, 2025

U.S.-listed shares of the world's largest brewer marked their worst day in over five years after the company missed revenue and volume estimates.

Via Stocktwits

Topics Government

US Judge Upholds FDA Decision To Remove Wegovy, Ozempic From Shortage List In Move Against Compounding Pharmacies ↗

June 18, 2025

The judge said that the FDA had appropriately weighed supply and demand data for the drugs and properly removed them from the shortage list, Reuters reported.

Via Stocktwits

Topics Lawsuit

Novo Nordisk’s Plan To Start Late-Stage Trial Of Investigational Obesity Drug Amycretin In 2026 Gets Retail Talking ↗

June 12, 2025

The decision to advance the study of subcutaneous and oral Amycretin into the late stage is based on feedback received from regulators following mid-stage studies.

Via Stocktwits

Novo Nordisk’s $812M Deal With Deep Apple Lifts Retail Mood, Chatter Spikes To High Levels ↗

June 11, 2025

Separately, chip-maker Nvidia also announced a collaboration with Novo Nordisk to accelerate drug discovery efforts through innovative AI use cases.

Via Stocktwits

Topics Artificial Intelligence Economy

Toyota Industries Likely To Accept $42B Takeover Bid From Toyota Motor And Group Companies, Says Report: Retail’s Undecided ↗

June 02, 2025

The consortium is expected to take Toyota Industries private after it accepts the tender offer, with the takeover bid estimated at 6 trillion yen, or approximately $42 billion.

Via Stocktwits

Topics Supply Chain

Toyota Records Fourth Straight Month Of Sales Jump In April: But Retail’s Not Yet Convinced ↗

May 29, 2025

The company reported a 25% jump in sales of electrified vehicles last month, owing to a 24% increase in sales of hybrid electric vehicles in particular, which touched 378,976 units.

Via Stocktwits

Topics Government World Trade

Novo Nordisk To Sell Wegovy For $199 A Month As Compounding Ban Nears: Retail’s Bullish ↗

May 22, 2025

The offer will be valid through June 30 and aims to encourage patients who previously used compounded versions of the drug to move to Wegovy.

Via Stocktwits

Novo Nordisk CEO Lars Jørgensen Steps Down Amid Challenges, Retail Chatter Spikes ↗

May 16, 2025

The company said it would announce the next CEO in “due course,” but did not provide a more definite timeline.

Via Stocktwits

Budweiser Maker AB InBev Plans $300M Investment To Expand US Production: Retail Turns Bullish ↗

May 13, 2025

As part of the plan, the company will also open a new plant in Ohio.

Via Stocktwits

Topics Government

Toyota Expects 21% Profit Decline In FY26: Retail’s In Wait-And-Watch Mode ↗

May 08, 2025

The company said that the new forecast includes a negative impact of 180 billion yen from U.S. tariffs for April and May, and an estimated 745 billion yen impact from the effects of the foreign...

Via Stocktwits

Topics World Trade

Novo Nordisk Stock Rises Pre-Market On Q1 Beat Despite Lowering Outlook – Retail’s Elated ↗

May 07, 2025

Sales of Novo Nordisk’s flagship weight loss drug Wegovy surged 85% in the first quarter of the fiscal year 2025, while its diabetes treatment Ozempic posted an 18% increase.

Via Stocktwits

Topics Earnings Law Enforcement

Why Is UBS Stock Trading Lower On Wednesday? ↗

April 30, 2025

UBS Group AG shares are down 1% Y/Y, with revenues of $12.56 billion missing consensus. CEO remains focused on clients and financial targets.

Via Benzinga

Novo Nordisk’s Weight-Loss Drug Wegovy Launched In Thailand, Marks Entry Into Southeast Asia ↗

April 28, 2025

Enrico Canal Bruland, vice president and general manager of Novo's Thai subsidiary, told Reuters that the firm received approval from the Thai FDA in 2023.

Via Stocktwits

Novo Nordisk Wins Another Legal Battle Against Compounding Of Wegovy, Ozempic: Retail’s Bullish ↗

April 25, 2025

Steve Benz, legal and US general counsel of Novo Nordisk, said the company is “pleased” that the court rejected the compounders' attempts to “undermine” the FDA's decision that the shortages of Wegovy...

Via Stocktwits

Topics Lawsuit

Genmab Stock Rises On Strong Darzalex Sales In Q1: Retail Remains Extremely Bullish ↗

April 15, 2025

Genmab receives royalties on the worldwide net sales of Darzalex, both the intravenous and subcutaneous products, under J&J's exclusive worldwide license to develop, manufacture, and commercialize...

Via Stocktwits

Topics Stocks

Novo Nordisk Warns Against Counterfeit Ozempic In US: Retail’s Unmoved ↗

April 14, 2025

The company said the seized counterfeit products feature lot number PAR0362 and illegitimate serial numbers beginning with the first eight digits, 51746517.

Via Stocktwits

Topics Economy

Novo Nordisk’s Controlling Shareholder Novo Holdings Reports Record Total Income, Investment Returns In 2024: Retail Stays Bullish ↗

April 02, 2025

The company said that its earnings consist of income from dividends and the share repurchase programmes of Novo Group companies Novo Nordisk A/S and Novonesis A/S, as well as returns from its...

Via Stocktwits

Novo Nordisk Stock Slips After BofA, Morgan Stanley Slash Price Targets – But Retail Goes Contrarian ↗

March 28, 2025

Bank of America analysts said Novo Nordisk might miss first-quarter estimates. According to TheFly, they expect the company to lower its full-year sales guidance from 16%-24% at constant exchange rates...

Via Stocktwits

Novo Nordisk Signs $2B Deal For Obesity Drug With Chinese Biotech: Retail Sentiment Improves ↗

March 24, 2025

Novo Nordisk will obtain exclusive worldwide rights to develop, manufacture, and commercialize the drug UBT251, while United Biotechnology will, however, retain the rights to the drug in mainland...

Via Stocktwits

Sony Stock Surges After Q3 Earnings Beat, Raised Outlook: Retail’s Not Convinced ↗

February 14, 2025

For full-year 2024, Sony expects revenue to be about JPY 13.2 trillion ($876 billion), 4% higher than its previous outlook.

Via Stocktwits

Topics Earnings

Sony Beats Q3 Earnings Expectations, PS5 And Streaming Revenues Growth Prompts Outlook Raise ↗

February 13, 2025

PlayStation parent Sony Group Corp reported strong Q3 results, with sales of $28.97B, beating estimates. EPS of $0.41 also beat expectations. PS5 sales drove growth.

Via Benzinga

Toyota Downgraded After Second Straight Profit Drop, But Stock Climbs As Annual Outlook Improves: Retail Stays Optimistic ↗

February 05, 2025

Toyota also announced plans to establish a wholly owned company in Shanghai to develop and produce Lexus BEVs and batteries.

Via Stocktwits

UBS Reports Strong Q4 Profit Growth, Warns Of Interest Income Decline ↗

February 04, 2025

UBS Group AG shares down after reporting $11.6B sales, 7% Y/Y growth & EPS of $0.23, beating consensus. Global Wealth Management's net new assets rose 10% Y/Y.

Via Benzinga

STMicroelectronics Q4 Earnings: 22% Revenue Drop, Sees Challenges With Lower Industrial and Auto Demand, Issues Weak Q1 Outlook ↗

January 30, 2025

STMicroelectronics reported Q4 net revenues of $3.32B, beating analyst estimates. EPS of $0.37 missed expectations. Net revenues aligned with outlook, driven by Personal Electronics. Book-to-bill ratio...

Via Benzinga

Sony Cancels Two Live-Service Games, Stays Committed to Long-Term Monetization ↗

January 17, 2025

PlayStation cancels unannounced live-service projects at Bend Studio and Bluepoint Games. Sony remains invested in live-service games and sold 3.8M PS5 units in Q2. Gaming industry faces challenges,...

Via Benzinga

What's Going With UBS Shares On Wednesday? ↗

September 11, 2024

UBS reaffirms commitment to Swiss market, to maintain $414B in loans despite rumors of cuts.

Via Benzinga

UBS Liquidates $2B Credit Suisse Real Estate Fund Amid Market Slump: Report ↗

August 15, 2024

UBS Group AG reportedly discloses $2B real estate fund from Credit Suisse into 'orderly liquidation' due to significant decline in value.

Via Benzinga

UBS Q2 Earnings Beats: Wealth Management Shines, Cost Savings Accelerate & More ↗

August 14, 2024

UBS Group reported strong Q2 sales of $11.9B, beating consensus. Gross cost savings of $0.9B achieved, with $7B expected by 2024. Merger with Credit Suisse complete, focusing on growth and cost...

Via Benzinga

< Previous 1 2 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Oil & Gas Journal starts where other industry publications stop. It delivers more than information; it delivers context, adding details the others leave out and combining them with analysis, commentary, industry trends, and statistics.

Newsletters

The top stories, industry insights and relevant research, assembled by our editors and delivered to your inbox.

Connect

http://www.facebook.com/ogjonline

https://www.linkedin.com/company/oil-&-gas-journal

http://twitter.com/ogjonline

Affiliated Brands

About Us
Advertise
Do Not Sell or Share
Privacy Policy
Terms & Conditions